Lupin Ltd - LUPIN Share Price

Sector: Pharmaceuticals | ISIN: INE326A01037
₹ 1,547.55 (-2.92%) icon19 Apr, 2024, 12:00:00 AM

Lupin Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/19/2024 12:00:00 AM

    ₹ 1547.55 -46.50 -2.92
  • Open
  • ₹ 1,575
  • Prev. Close
  • ₹ 1,594.05
  • Turnover(Lac.)
  • ₹ 18,360
  • Day's High
  • ₹ 1,584
  • Day's Low
  • ₹ 1,541
  • 52 Week's High
  • ₹ 1,704.25
  • 52 Week's Low
  • ₹ 678.55
  • Book Value
  • ₹ 446.6
  • Face Value
  • ₹ 2
  • Mkt Cap (₹ Cr.)
  • 70,529.61
  • P/E
  • 34.21
  • EPS
  • 45.22
  • Divi. Yield
  • 0.26

Lupin Ltd Corporate Actions

22 Mar , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

24 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

24 Jan , 2024

12:00 AM

25 Oct , 2023

12:00 AM

25 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

21 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

21 Jul , 2023

12:00 AM

04 Jul , 2023

12:00 AM

AGM

Announcement date: 04 Jul , 2023

View Details

09 May , 2023

12:00 AM

Dividend

Dividend amount: 4
Announcement date: 09 May , 2023

View Details

25 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Apr , 2023

12:00 AM

No Record Found


Lupin Ltd News and Update

Image not found

He will be located in Mumbai and would be in charge of Lupin's technical operations.

Image not found

Lupin launches generic fertility drug Ganirelix Acetate in the US

It is the generic equivalent of Organon USA LLC's Ganirelix Acetate Injection, 250 mcg/0.5 mL, which is reference listed (RLD).

  • 16 Feb, 2024 |
  • 9:26 AM
Image not found

Q3FY24 Review: Lupin: Aspiring for further margin expansion

Recommendation: Add; Target price: ₹1590

  • 09 Feb, 2024 |
  • 1:34 PM
Image not found

Lupin Soars: Q3 Revenue Up 20%, Net Profit Quadruples to ₹613 Crore

Revenue increased to ₹5,197.4 Crore from ₹4,322.2 Crore in the same quarter last year.

  • 08 Feb, 2024 |
  • 11:47 AM

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Lupin Ltd SHAREHOLDING SNAPSHOT
21 April , 2024 | 01:33 AM

PROMOTER - TOTAL47.01%

Indian: 46.73%

Foreign: 0.2823%

NON-PROMOTER - TOTAL 52.99%

Institutions: 46.06%

Non-Institutions: 6.93%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Lupin Ltd FINANCIALS

Lupin Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Lupin Ltd

  • M D Gupta
  • Chairman (Non-Executive)
  • Nilesh Deshbandhu Gupta.
  • Managing Director
  • Vinita Gupta
  • Director & Chief Executive Off
  • R V Satam
  • Company Sec. & Compli. Officer
  • Jean-Luc Belingard
  • Independent Director
  • Ramesh Swaminathan
  • Executive Director & CFO
  • Mark D McDade
  • Independent Director
  • K B S Anand
  • Independent Director
  • Punita Kumar Sinha
  • Independent Director

Summary

Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments.Lupin Ltd was incorporated in the year 1983 with the name Lupin Chemicals Ltd. In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar. In the year 1989, the company established a joint venture in Thailand, namely Lupin Chemicals (Thailand) Ltd. In the year 1991, they initiated production of Injectable cephalosporin (bulk and dosages) at Mandideep. In the year 1992, the company set up Fermentation Plant at Tarapur, Maharashtra. Also, Sterile Plant for injectable Cephalosporins (bulk) was commissioned at Mandideep.In the year 2001, Lupin Laboratories Ltd was amalgamated with the company and the name was changed to Lupin Ltd. They commenced supply of Cephalosporin bulk actives to their alliance partners in the US. Also, they commissioned a state of the art US FDA approvable oral cephalosporin bulk active plant. In the year 2002, the company commissioned the new Anti-TB facility at Aurangabad. In the year 2003,... Read More


Reports by Lupin Ltd


Reports by Lupin Ltd

Company FAQ

What is the Market Cap of Lupin?

Is Lupin part of Nifty 50?

What is the dividend of Lupin in 2023?

Is Lupin a debt-free company?

Is Lupin a good stock to buy?

What is the future of Lupin Limited's shares?

What is Lupin Ltd Share symbol?

Who is/are the promoter/promoters of Lupin Ltd?

Who are peers of Lupin Ltd?

Who's the owner of Lupin?

What is the 52 Week High and Low of Lupin?

What is the PE and PB ratio of Lupin?

What is the Share Price of Lupin?

How to Buy Lupin Share?